Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Cissus quadrangularis contains flavonoids like quercetin and triterpenoids that upregulate RUNX2 via MAPK/Wnt pathways to promote osteoblast activity and bone healing. The plant's bioactive compounds inhibit inflammatory cytokines IL-6 and TNF-α while reducing oxidative stress through β-carotene-mediated free radical scavenging.
Reported Benefits (Provisional)
Origin & History
Cissus quadrangularis is a perennial plant native to the arid regions of India, Sri Lanka, Southeast Asia, and Africa. Revered in traditional medicine, it is valued for its exceptional capacity to accelerate bone healing, reduce joint inflammation, and support metabolic and hormonal balance.
Research Narrative (Provisional)
Scientific studies, including those referenced in PubMed and ScienceDirect, have investigated Cissus quadrangularis for its bone-healing properties, anti-inflammatory effects, and metabolic support. Research highlights its potential in musculoskeletal health and weight management.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Contains ketosteroids, quercetin, triterpenoids, phytosterols, mucilage, and stilbenes (including resveratrol derivatives). - Vitamins: Rich in Vitamin C and carotenoids. - Minerals: Provides calcium, phosphorus, and magnesium.
Reported Mechanism (Provisional)
Key compounds including quercetin, genistein, and triterpenoids like friedelin upregulate RUNX2 transcription factor via MAPK/Wnt signaling pathways, enhancing osteoblast markers such as alkaline phosphatase, collagen I, and osteocalcin. The plant inhibits RANKL/OPG ratio and suppresses pro-inflammatory cytokines IL-17, IL-6, and TNF-α to prevent osteoclast formation. β-carotene and other antioxidants scavenge DPPH radicals and reduce lipid peroxidation while promoting S-phase cell cycle progression.
Clinical Narrative (Provisional)
Animal studies demonstrate significant efficacy, with rat models showing 40% improvement in radiographic bone healing and 60% reduction in NSAID-induced gastric lesions compared to controls. Joint health studies using 300-500 mg/kg extract in rats reduced oxidative stress and inflammatory cytokines, while SOD antioxidant activity increased by 25%. In vitro studies on MG-63 osteoblast cells confirm biphasic osteogenic effects, though human clinical trials with quantified outcomes are currently lacking. Most evidence derives from preclinical animal and cell culture studies rather than controlled human trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.